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Diabetic cardiomyopathy refers to the manifestations in the heart as a result of altered glucose homeostasis, reflected as fibrosis,
cellular hypertrophy, increased oxidative stress, and apoptosis, leading to ventricular dysfunction. Since physical exercise has
been indicated as cardioprotective, we tested the hypothesis that high-intensity exercise training could reverse the cardiac
maladaptations produced by diabetes. For this, diabetes was induced in rats by a single dose of alloxan. Diabetic rats were
randomly assigned to a sedentary group or submitted to a program of exercise on a treadmill for 4 weeks at 80% of maximal
performance. Another group of normoglycemic rats was used as control. Diabetic rat hearts presented cardiomyocyte
hypertrophy and interstitial fibrosis. Chronic exercise reduced both parameters but increased apoptosis. Diabetes increased the
myocardial levels of the mRNA and proteins of NADPH oxidases NOX2 and NOX4. These altered levels were not reduced by
exercise. Diabetes also increased the level of uncoupled endothelial nitric oxide synthase (eNOS) that was not reversed by
exercise. Finally, diabetic rats showed a lower degree of phosphorylated phospholamban and reduced levels of SERCA2 that
were not restored by high-intensity exercise. These results suggest that high-intensity chronic exercise was able to reverse
remodeling in the diabetic heart but was unable to restore the nitroso-redox imbalance imposed by diabetes.
1. Introduction
Diabetes mellitus is one of themost common chronic diseases
all over the world, becoming an epidemic, triggered probably
by reduced physical activity and increased obesity in the pop-
ulation [1, 2]. Diabetic cardiomyopathy is the deterioration
of the myocardial function and morphology produced by the
altered glucose homeostasis imposed in diabetes, independent
of coronary disease [3].Diabetic cardiomyopathy is character-
ized initially bydiastolicdysfunctionandcardiachypertrophy,
with preserved ejection fraction. At the cellular level, the
diabetic myocardium presents myocyte hypertrophy,
interstitial fibrosis, and apoptosis [4]. This process of cardiac
deterioration involves the generation of reactive oxidative spe-
cies (ROS) [5]. Oxidative stress exists when the production of
ROS outweighs their degradation by antioxidant systems [6].
The resultant elevation of ROS has numerous harmful effects
on the cardiovascular systemvia cellular damage by oxidation,
disruption of vascular homeostasis through interference with
NO, and detrimental intracellular signaling pathways [7]. In
a variety of animal models of diabetes and humans with dia-
betic cardiomyopathy, there is excessiveROSproduction from
bothmitochondrial and extramitochondrial sources, andROS
have been implicated in all stages of the development of heart
failure, from cardiac hypertrophy to fibrosis, contractile
dysfunction, and failure [5, 8].
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Several ROS sources contribute to the observed oxidative
stress in the diabetic heart such as xanthine oxidoreductase
(XOR) [9], nicotinamide adenine dinucleotide phosphate
(NADPH) oxidases (NOX) [10], mitochondria [9], and
uncoupled nitric oxide synthases (NOS) [10–13].
A direct consequence of the increased production of reac-
tive oxygen species (ROS) is NOS uncoupling. This is the
aftermath of the oxidation of tetrahydrobiopterin (BH4), an
essential cofactor for NOS activity. When NOS is uncoupled,
its activity is redirected towards the production of superox-
ide, instead of nitric oxide (NO), further contributing to the
oxidative process.
Physical exercise is prescribed as part of the rehabilitation
for patients with heart diseases since it reduces cardiac risk
factors, protects against myocardial damage, and improves
cardiac function [14]. In type 2 diabetic patients, exercise is
also advised as part of the nonpharmacological treatment,
since it exerts a number of benefits such as improved insulin
sensitivity and reduction in body weight [15]. Nevertheless,
there is less information regarding type 1 diabetic patients.
A recent report indicates that intense exercise is associated
to reduction in the risk of cardiovascular events in type 1
diabetes patients [16]. In animal models of type 1 diabetes,
low-to-moderate exercise training has been found to improve
cardiac glucose metabolism [17], reduce apoptosis [18], and
improve ventricular function [19].
The intensity of exercise for diabetic patients is a
matter of intense investigation, being suggested that in
particular, high-intensity interval training may confer
additional cardiometabolic protection [20]. For instance,
while moderate-intensity exercise did not improved car-
diac function in type 2 diabetic patients [21], a similar
study but with a high-intensity interval training showed
improved cardiac function and remodeling [22]. Another
study showed no difference between moderate- and high-
intensity exercises [23], although this later did not include
the assessment of cardiac parameters.
As mentioned before, in animal models of type 1 diabe-
tes, low- and moderate-intensity exercise have been reported
to reverse or prevent some of the cardiac maladaptations of
diabetic cardiomyopathy [18, 24]. Nevertheless, the informa-
tion regarding high-intensity exercise in diabetic cardiomy-
opathy is less abundant.
The mechanisms by which exercise may produce it bene-
ficial effects include an increase in nitric oxide production
[25] and a reduction in oxidative stress [26]. In this work,
we tested the hypothesis that a high-intensity exercise train-
ing program could reverse the cardiac maladaptations and
oxidative stress that are produced by diabetes.
2. Methods
2.1. Animals and Training Protocol. Diabetes was induced in
3-month-old male Sprague–Dawley rats by a single dose of
alloxan (Sigma-Aldrich, St. Louis, MO), 200mg/kg, intraper-
itoneal. Six days day after alloxan injection, hyperglycemia
was confirmed (plasma glucose levels >300mg/dL). Diabetic
rats were randomly assigned to a sedentary group (n = 5) or
submitted to a program of exercise on a motor-driven
treadmill, 5 days/week, for 4 weeks. The maximal intensity
of the training for each rat was assessed by stepwise increases
in the treadmill speed. Two days prior to the test, the animals
were submitted to a period of acclimatization in the tread-
mill, walking at 0.6 km/h, twice a day, the first day. During
the second and third days, the incremental velocity test was
applied that consisted of increasing the treadmill velocity
from 0.6 km/h to 0.2 km/h every 3min, with no upper limit,
until the animal reached exhaustion that defines the end of
the test. The angle of the treadmill was kept constant at 0°.
Once the animal reached its maximal velocity for at least 3
minutes, this value was assigned as the maximal performance
(100%). Then, the animal was trained at the 80% of its capac-
ity (velocity and time), once a day, five days a week, for four
weeks. Every week, maximal capacity was reevaluated for
each animal, to adjust its training load for the next week.
To determine the duration (in minutes) of the training, a
tolerance test was applied that consisted in determining the
maximal time that the rat was able to sustain the 80% of
the velocity previously determined. Finally, the training con-
sisted of the 80% of the maximal velocity for the 80% of max-
imal time. This finally determines the volume of training for
each animal. The rats were maintained in the animal facility
of the Universidad de Talca, with food and water ad libitum,
at room temperature (22± 5°C) and with cycles of 12 hrs
light/darkness. The diet used was obtained from Champion®
(20.5% crude protein, 5% fiber, 4% fat). A group of normo-
glycemic rats was used as control (n = 7). Finally, the rats
were euthanized after two days after the training protocol fin-
ished, to avoid potential confounding effects of acute exer-
cise. To extract the heart, the animals were induced deep
anesthesia with ketamine (75mg/100 g body weight) and
xylazine (15mg/100 g body weight), checking for the com-
plete absence of sensitive reflexes.
Plasma glucose determinations were performed using the
glucose oxidase system (Valtek Diagnostics, Santiago, Chile),
following the manufacturer instructions, and using a spectro-
photometer (Rayleigh UV-9200).
All procedures were performed in conform to the NIH
Guide for the Care and Use of Laboratory Animals. The pro-
tocol was approved by the Bioethical Committee of the
Universidad de Talca.
2.2. Histological Staining. After excision, hearts were fixed in
4% paraformaldehyde. After fixation, the samples underwent
a series of dehydrations and were embedded in paraffin
blocks. After this, 5μm sections were obtained with a
MicromHM 325 microtome and then mounted on xylanized
slides. Sections of hydrated and deparaffinized xylene tissue
were stained with hematoxylin and eosin (H&E), used for
TUNEL analysis or Sirius red staining.
2.3. Assessment of Cardiac Apoptosis. Apoptosis was evalu-
ated by the TUNEL assay [27], which detects fragmented
DNA in situ in the cell nucleus. The assay was performed
using the TUNEL Apoptosis Detection Kit (EMD Millipore,
Temecula, CA), according to the manufacturer’s instructions
with some modifications. Cardiac sections prepared as above
indicated, then incubated with 50μL of proteinase K for
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30min in a humid chamber and washed with PBS. Then, sec-
tions were incubated with the TdT end-labeling cocktail that
contains TdT and biotinylated dUTP, for 5min at room
temperature. Each step was followed by PBS washes. Then,
sections were incubated with blocking buffer for 20min at
room temperature. After this, FITC-labeled avidin was
applied for 30min at 37°C in a humid chamber. Sections were
washed twice with PBS for 15min at room temperature in the
dark and then counterstained with propidium iodide
(1 : 2000) for 15min. Sections treated with DNAse I was used
as positive controls. Sections in which treatment with pro-
teinase K was replaced by PBS were used as negative control.
After finishing the protocol, sections were observed with a
Zeiss LSM-700 confocal microscope and TUNEL positive
cells and total cells were counted. The apoptotic index repre-
sents the number of TUNEL+ cells to total number of cells.
This percentage was compared between groups.
2.4. Real-Time PCR. For quantitative polymerase chain reac-
tion (qPCR), total RNA was extracted from rats hearts using
TRIzol reagent and reversed transcribed using high capacity
cDNA reverse transcription kit (Applied Biosystems, Foster
City, CA). qPCR was performed in triplicate for each heart,
using a 20μL mixture containing 1ng cDNA, TaqMan Mas-
ter Mix, and TaqMan® Gene Expression Assays (Applied
Biosystems) for NOX2 (Rn00576710_m1) and NOX4
(Rn00585380_m1). As an internal control, glyceraldehyde
3-phosphate dehydrogenase GAPDH (Rn01775763_g1) was
determined in each reaction. Reaction conditions were set
according to the manufacturer: one cycle of 50° for 2min,
one cycle of 90° for 10min, and 40 cycles of 15 s at 95° and
60° for 1min using an Mx3000P qPCR system (Agilent Tech-
nologies, CA, USA). Relative fold change was calculated by
the 2ΔCt method and compared with baseline values as previ-
ously described [28].
2.5. Biopterin Measurements. Tetrahydrobiopterin (BH4) and
dihydrobiopterin (BH2) were measured form cardiac homog-
enates, following the procedure described by Fukushima and
Nixon [29], with modifications, by HPLC (Perkin Elmer
series 200) separation and fluorescence detection at 350 nm
(Shimadzu RF-20A). The procedure involves a differential
oxidation BH4 and BH2 with iodine in acidic and basic con-
ditions. In acidic conditions, both BH4 and BH2 are oxidized
to biopterins, while under basic conditions, only BH2 is oxi-
dized to biopterin. The difference in the content of biopterin
between both oxidations represents the amount of BH4.
Intracardiac BH4 content was normalized to the total protein
content of the sample.
2.6. Western Blotting. Cardiac tissue was homogenized in
3mL of lysis buffer (Tris 50mM, SDS 0.1%, NaCl 30mM,
EDTA 2mM) supplemented with 30 μL proteases inhibitors
cocktail (MP Biomedicals, Solon, OH) using an ultraturrax,
as previously described [30]. Then, the homogenate was cen-
trifuged at 4000 rpm for 10min at 4°C. The supernatant was
removed and protein concentration was quantified using the
BCA method (BCA Protein Assay Kit, Thermo Fisher Scien-
tific, Rockford, IL). For this, 100 μg of protein were mixed
with Laemmli buffer, separated by SDS-PAGE, and blotted
onto nitrocellulose membranes (Bio-Rad Laboratories,
Hercules, CA). Antibodies used were the following: for
NOX2 (anti-gp91phox 1 : 1000, catalog number: 611415, Lot:
15660), p67phox (1 : 1000, catalog number: 610913, Lot:
000079141) and eNOS (1 : 2000, catalog number: 610297,
Lot: 35170) from BD Biosciences (San Jose, CA); for NOX4,
from Thermo Scientific (1 : 1000, catalog number: PA1-
46014), serine 16 phosphorylated phospholamban (1 : 1000,
catalog number: A010-12, Lot: 0214-01) and total phospho-
lamban (1 : 1000, catalog number: A101-14, Lot: 642016)
were obtained from Badrilla (Leeds, UK); SERCA2 (1 : 2000,
catalog number: SC 8094, Lot: C1115); GAPDH (1: 1000,
catalog number: SC-365062, Lot: A2715); and secondary
antibodies from Santa Cruz (Santa Cruz, CA). The protein
bands were visualized using Supersignal West Femto Reagent
(Pierce, Rockford, IL). Western blots were scanned and
bands were quantified by densitometry analysis using ImageJ
software.
2.7. Statistical Analysis. Results are expressed as mean± stan-
dard error. Comparisons between groups were performed
using one-way analysis of variance (ANOVA) with
Newman-Keuls and Dunnett as post hoc analysis, for data
with normal distribution. For nonparametric data, Kruskal-
Wallis test was applied, with Dunn’s multiple comparisons
test as post hoc analysis. Analysis of exercise training was
performed using ANOVA with repeated measures. Statistical
significance was set at a value of p < 0 05. These analyses were
performed using the SPSS statistical package and the Graph-
Pad Prism 5 software (San Diego, CA).
3. Results
3.1. Alloxan-Induced Diabetes in Rats. Alloxan injection
induced hyperglycemia in rats as expected for a type 1 model
of diabetes (Table 1). Control animals increased body weight
while both diabetic groups showed a slight weight reduction.
All the animals in the training group completed the protocol
and increased significantly their aerobic capacity (Figure 1).
Diabetic rats submitted to the exercise protocol showed
reduced plasma glucose levels compared to the sedentary dia-
betic rats (p < 0 05).
Exercise training tests at baseline (before diabetes) for
maximal velocity and maximal time were performed. These
tests were repeated after the induction of diabetes (week 0)
and with these values was estimated the 80% of maximal per-
formance that were used the next week of training for each
animal. In the subsequent weeks, this procedure was
repeated. In this way, diabetic rats increased their exercise
capacity significantly (see Figure 1), specially the maximal
velocity that increased each week, although they did not
reach the baseline values (before diabetes). Nevertheless, at
the end of the third and fourth week of training, the test max-
imal capacity (velocity and time) tests were not performed.
3.2. Cardiac Morphology. As it has been previously described,
as part of the remodeling process that takes place in the
diabetic heart, diabetes induced cellular hypertrophy of
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cardiomyocytes (Figure 2). Compared to the hearts from
control normoglycemic rats, diabetic rat hearts presented
increased perimeter of cardiomyocytes: 73± 7μm in the con-
trol group and 89.5± 4.3μm in the diabetic group (p < 0 05),
and this value was reduced in diabetic rats that underwent
exercise: 78.7± 2μm. Consistent with this, myocyte area
was increased in diabetic hearts compared to that in controls
and reduced in animals that underwent physical training:
297± 17μm2 in control rats, 446± 26m2 in diabetic rats,
and 363± 14μm2 in the diabetic + exercise group (p < 0 05).
As expected, diabetes induced an increase in fibrosis as
collagen deposition in the heart as part of the cardiac damage
(Figure 3). Nevertheless, chronic exercise reduced cardiac
fibrosis: 4.43± 0.9% of fibrosis in the control group, 8.68
± 0.7% in diabetic rats, and 5.72± 0.7% diabetic hearts from
the rats that underwent high-intensity exercise.
3.3. Apoptosis. It has been observed that diabetes is associated
with increased degree of apoptosis in the myocardium [31].
For this reason, we investigated this type of cell death in
our experimental animals, using the TUNEL assay
(Figure 4). In the control normoglycemic and diabetic rats,
the level of apoptotic index was low: 1.9± 2.2 and 1.5± 2%,
respectively. Unexpectedly, this level was increased substan-
tially in the diabetic + exercise group: 6.5± 10.2% (p < 0 05).
These data suggest that high-intensity exercise training
induced an increase in cardiomyocytes apoptotic death.
3.4. NADPHOxidases.Diabetes is associated with an increase
in oxidative stress in the myocardium, particularly derived
from NADPH oxidases as source of reactive oxygen species
[32]. For this reason, we first looked into the expression at
the level of NOX2 and NOX4 mRNA (Figure 5), the two
main isoforms of NADPH oxidases that are expressed in
the heart and, specifically, in the cardiac myocyte. Diabetes
induced a twofold increase in the NOX2 mRNA level,
compared to control normoglycemic animals (p < 0 05).
Unexpectedly, exercise increased this level about eightfold.
In the case of NOX4, diabetes also increased the mRNA
levels (p < 0 05), and in the diabetes + exercise group, this
increase was even more pronounced, although with sub-
stantial variability.
Next, we tested whether this increase in the NOX mRNA
levels was followed by increased protein expression. For this
purpose, we performed SDS-PAGE and Western blotting
assays of cardiac samples (Figure 6). In the case of the protein
levels of NOX2, both the diabetes and diabetes + exercise
groups showed about a sevenfold increase. In the case of
NOX4, there was a trend of increase but not statistically
significant. On the contrary, the levels of p67phox, one of
the regulatory subunits of NOX2, also showed a significant
increase in the diabetic + exercise group (p < 0 05). These
data suggest that the components of NOX2 are upregulated,
increasing the levels of myocardial oxidative stress, especially
in the group submitted to high-intensity exercise training.
Table 1: Body weight and plasma glucose.
Parameters Control Diabetic Diabetic + exercise p value
Baseline body weight, g 307.5± 7.5 333.0± 8.6 335.0± 10.6 0.1258
Final body weight, g 452.5± 19.3 318.0± 6.2† 298.0± 26.1† 0.0004
Baseline plasma glucose (mg/dL) 87.0± 8.7 78.0± 2.0 100.6± 4.5 0.0501
Plasma glucose at the beginning of training (mg/dL) 78.7± 3.5 573.5± 44.1† 516.6± 72.7† <0.0001
Plasma glucose at the end of training (mg/dL) 108.4± 5.8 587.9± 15.9† 476.7± 42.6†† <0.0001
†p < 0 005 versus control; ††p < 0 05 versus diabetic.
Maximal time


































Figure 1: High-intensity training. Maximal time (min) and velocity (km/h) test. Rats were submitted to an exercise test before (control)
and after induction of diabetes. Week 0 corresponds to the time point after the confirmation of diabetes. From week 0, the result of each week
test was used to calculate the 80% of maximal capacity for the next week training. Then, every week, a maximal capacity test was performed.
†††p < 0 005 versus all the other groups; ∗∗∗p < 0 005 versus week 0; ∗∗p < 0 001 versus week 0; ∗p < 0 05 versus week 0.
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3.5. Nitric Oxide Synthase. Next, we examined the nitric
oxide pathway, which has been shown to be cardioprotective.
First, we evaluated the cardiac levels of the endothelial nitric
oxide synthase, by Western blotting (Figure 7). Neither
diabetes nor exercise induced changes in the levels of eNOS
(p = 0 4139).
A direct consequence of the increased production of reac-
tive oxygen species (ROS) is the uncoupling of nitric oxide
synthase. The oxidation of BH4, an essential cofactor for
NOS activity, leads to the dissociation of NOS as a dimer into
monomers. We quantified the levels of eNOS as a dimer and
a monomer by Western blot under nonreducing conditions
(Figure 7). This analysis revealed that diabetes induced
strong eNOS uncoupling, increasing the formation of its
monomer. High-intensity exercise was unable to restore
eNOS as dimer. The eNOS dimer/monomer ratio was 1.3
± 0.4 in the control group, 0.38± 0.04 in the diabetic group,
and 0.26± 0.03 in the diabetic + exercise group (p < 0 05).
Furthermore, exercise was unable to restore the intracar-
diac levels of BH4, an essential cofactor for NOS activity,
that were reduced in diabetic rats: 111.1± 49.2 pmol/g pro-
tein in the control group, 17.9± 2.6 in the diabetic group,
and 17.4± 3.7 in the diabetic + exercise group (p < 0 05).
This result explains that both diabetic groups showed
increased eNOS as monomer, in the uncoupled state. In
most samples, BH2 levels were undetectable, for this rea-
son, results are expressed as BH4 normalized to protein
concentration, instead of a ratio BH4/BH2.
3.6. Calcium Handling Proteins. Finally, we evaluated the
level of Ca2+ handling proteins, to gain information regard-
ing the status of the excitation contraction coupling elements
in the diabetic hearts. Phospholamban (PLB) is a negative
regulator of the sarcoplasmic calcium pump SERCA2 [33].
When PLB phosphorylated at serine 16 (by protein kinase
A), it unleashes SERCA2 from its inhibition, being able to




























































Figure 2: Cardiac hypertrophy inducedbydiabetes. Cardiac sectionswere stainedwithhematoxylin and eosin (see the photomicrographs). The
bar graphs depict the statistical analysis for cellular hypertrophy (area and perimeter) in the control (nondiabetic), diabetic, and diabetic

































Figure 3: Cardiac fibrosis induced by diabetes. Cardiac sections
were stained with Sirius red (see the photomicrographs). The
bar graphs depict the statistical analysis for fibrosis in the
control (nondiabetic), diabetic, and diabetic + exercise (diabetes
EX) rats. N = 5 hearts in each group. The scale bar indicates
50μm. ∗∗p < 0 01 versus control.
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While the total levels of PLB were not altered by diabetes
(Figure 8), the degree of PLB phosphorylation at serine 16
was reduced in diabetic animals and was not recovered by
exercise (p < 0 05), suggesting impaired intracellular Ca2+
handling. We also assessed the levels of SERCA2. Both dia-
betic groups presented decreased levels of SERCA2 com-
pared to nondiabetic rats (p < 0 05), which is associated
with cardiac dysfunction, as the capacity to store Ca2+ in
the sarcoplasmic reticulum is reduced (systolic function),
and the velocity of relaxation is reduced (diastolic function).
4. Discussion
Exercise appears as an effective strategy for diabetic patients
and has been recommended in moderate and high intensity
[15]. In this study, we evaluated the effects of a high-
intensity physical exercise training protocol on cardiac
remodeling and myocardial proteins involved in the
nitroso-redox balance in an animal model of type 1 diabetes.
We found that this training program had a positive impact














































Figure 4: Cardiac apoptosis. Assessment of apoptosis by TUNEL. (a) Photomicrographs (green channel) show the positive nuclei for the
TUNEL reaction of the representative cardiac sections from the control (nondiabetic), diabetic, and diabetic + exercise rats, n = 5 hearts in
each group. (b) Photomicrographs (red channel) show total nuclei of the same sections stained with propidium iodide. (c)
































































Figure 5: NOX2 and NOX4 mRNA expression in diabetic hearts. Quantification for NOX2 and NOX4 mRNA, normalized to the levels of
GAPDH, by real-time PCR, from the control (nondiabetic), diabetic, and diabetic + exercise (diabetic EX) rat hearts; n = 3 hearts in each
group. ∗p < 0 05 versus control.
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hypertrophy and reduced collagen deposition (fibrosis), but
was unable to restore the nitroso-redox environment.
NADPH oxidase 2 system (NOX2) was upregulated; there
were no changes in eNOS levels, but the degree of eNOS
uncoupling was increased, being a potential additional source
of superoxide. Furthermore, this probably increase in
oxidative stress was associated with increased degree of car-
diac apoptosis in diabetic animals submitted to the exercise
program and reduced phospholamban phosphorylation.
These data also suggest that the reverse remodeling process
may be independent of increased oxidative stress. For exam-
ple, it has been suggested that moderate-intensity training
decreases myocyte cross-sectional area [24]. Interestingly,
the high-intensity training increased the degree of apoptosis.
This is contrary to what has been observed in rats under low-
intensity exercise [18], which reduced the apoptotic index
associated with a recovery in the level of antioxidant enzymes
glutathione peroxidase, catalase, and superoxide dismutase.
Nevertheless, in that study, plasma levels of glucose reached
about 300mg/dL in the diabetic animals, much lower com-
pared to those in our study (around 600mg/dL in the diabetic
rats). In another recent study, Gimenes et al. in a similar low-
intensity exercise protocol also observed a recovery in the
cardiac levels of catalase and glutathione peroxidase, with
glucose plasma levels around 500mg/dL (similar to this
study) [34].
Regarding the NADPH oxidase system, diabetes induced
an increase in both NOX2 and NOX4 mRNA that was not
reversed by exercise. Furthermore, NOX2 protein and
p67phox, one of its regulatory subunits, were also increased
in diabetes and not reversed by exercise, strongly suggesting
an increased ROS production.
In a recent report, Sharma et al. described that in a
protocol of exercise similar to ours, they observed a reduc-
tion in the levels of the mRNA (although not measured by
quantitative PCR) and protein of p47phox and p67phox, the
regulatory subunits of NOX2, in the left ventricle of














































































Figure 6: NOX proteins expression in diabetic cardiomyopathy. Representative Western blots for NOX2, NOX4, and p67phox in the control
(nondiabetic), diabetic, and diabetic + exercise (diabetic EX) rat hearts. The bar graphs indicate the densitometry analysis for 5 hearts of each
group, normalized by GAPDH levels. ∗p < 0 05 versus control.
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the plasma glucose levels in diabetic animals attained
about 300mg/dL, which appears to be in important factor
on the observed results.
It is possible that the reverse remodeling observed in the
exercise-trained rats may be independent of oxidative stress
but dependent, for example, on reverse of metabolic path-
ways such as nonoxidative glucose pathways [26]. In our
study, exercise reduced the plasma levels of the advanced gly-
cation end-products (AGEs, data not shown) in the diabetic
animals. On the other hand, NOX-derived ROS may have
induced signaling pathways converging, for instance, in
increased autophagy [36, 37]. Autophagy is a homeostatic
process important during stress conditions, aimed to obtain
energy and amino acids from the degradation of proteins
and organelles [38]. ROS produced by NOX2 and 4 may
increase the process of autophagy in the diabetic heart. This
increased autophagic flux may be beneficial for the diabetic
heart [39].
Interestingly, our study showed an increase in the degree
of uncoupling of the enzyme, associated with a reduction of
the NOS cofactor BH4. It is possible that the increased oxida-
tive stress derived from NOX2 and other sources may have
been responsible for the reduced levels of BH4, since this
molecule has been shown to be redox sensitive [40, 41].
Strategies to recover cardiac BH4 in diabetic animals
have shown promising results reducing remodeling and
improving ventricular function [11, 13]. Farah et al.
showed that a high-intensity exercise increased the degree
of eNOS dimerization [42]. Nevertheless, this increase was
lost upon ischemia and even reduced upon reperfusion.
This reinforces the concept that eNOS uncoupling is
induced by oxidative environments, as those observed in
cardiovascular diseases and diabetes [43–45].
In addition, it has been shown that NOS activity is related
to phospholamban phosphorylation [46], a key protein in the
regulation of the excitation-contraction coupling, as a regula-
tor of SERCA2. On the other hand, it has been reported that
diabetes reduces phospholamban phosphorylation [33, 46],
in agreement with our observations. Exercise was unable to
restore this phosphorylation, probably reducing the capacity
of the sarcoplasmic reticulum for Ca2+ reuptake, along with
the reduced levels of SERCA2. Nevertheless, in the diabetic
heart, other abnormalities in the excitation-contraction cou-
pling machinery are also present, like the ryanodine receptor
and the Na/Ca exchanger [47–49].
Another possibility is that exercise training may have
reduced inflammatory mediators in the diabetic myocar-
dium. da Silva et al. found in rats treated with streptozotocin
that a low-intensity swimming training reduced intramyo-
cardial levels of TNF-alpha associated with a reverse remod-
eling of the diabetic hearts [50].
5. Conclusions
In conclusion, the present results suggest that high-intensity
exercise is able to reverse cardiac remodeling in the diabetic




































































































Figure 7: eNOS uncoupling in diabetes. (a) Representative Western blot for eNOS as dimer and monomer, and total cardiac eNOS from
control (non-diabetic), diabetic and diabetic + exercise rats hearts (diabetic EX), n = 5 hearts each group. (b) Quantification for cardiac
levels eNOS. (c) Ratio of dimer to monomer eNOS. (d) Intracardiac levels of tetrahydrobiopterin (BH4).
∗p < 0 05 versus control.
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heart but is unable to restore the nitroso-redox imbalance
imposed and observed in this condition. This later could by
restored by pharmacological manipulations that may include
antioxidants and tetrahydrobiopterin.
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